REVIEW published: 08 November 2018 doi: 10.3389/fendo.2018.00654 Frontiers in Endocrinology | www.frontiersin.org 1 November 2018 | Volume 9 | Article 654 Edited by: Vance L. Trudeau, University of Ottawa, Canada Reviewed by: Taisen Iguchi, National Institute for Basic Biology, Japan Marzia Di Donato, Università degli Studi della Campania “Luigi Vanvitelli” Caserta, Italy *Correspondence: Francesca Maradonna f.maradonna@univpm.it Oliana Carnevali o.carnevali@univpm.it These authors have contributed equally to this work Specialty section: This article was submitted to Experimental Endocrinology, a section of the journal Frontiers in Endocrinology Received: 10 August 2018 Accepted: 18 October 2018 Published: 08 November 2018 Citation: Maradonna F and Carnevali O (2018) Lipid Metabolism Alteration by Endocrine Disruptors in Animal Models: An Overview. Front. Endocrinol. 9:654. doi: 10.3389/fendo.2018.00654 Lipid Metabolism Alteration by Endocrine Disruptors in Animal Models: An Overview Francesca Maradonna 1,2 * and Oliana Carnevali 1,2 * 1 Dipartimento Scienze della Vita e dell’Ambiente, Università Politecnica delle Marche, Ancona, Italy, 2 INBB Consorzio Interuniversitario di Biosistemi e Biostrutture, Rome, Italy Exposure to potential Endocrine Disrupting Chemicals (EDCs) pose a documented risk to both wildlife and human health. Many studies so far described declining sperm counts, genital malformations, early puberty onset, highlighting the negative impact on reproduction caused by the exposure to many anthropogenic chemicals. In the last years, increasing evidence suggested that these compounds, other than altering reproduction, affect metabolism and induce the onset of obesity and metabolic disorders. According to the “environmental obesogens” hypothesis, evidence exists that exposure to potential EDCs during critical periods when adipocytes are differentiating, and organs are developing, can induce diseases that manifest later in the life. This review summarizes the effects occurring at the hepatic level in different animal models, describing morphological alterations and changes of molecular pathways elicited by the toxicant exposure. Results currently available demonstrated that these chemicals impair normal metabolic processes via interaction with members of the nuclear receptor superfamily, including steroid hormone receptors, thyroid hormone receptors, retinoid X receptors, peroxisome proliferator–activated receptors, liver X receptors, and farnesoid X receptors. In addition, novel results revealed that EDC exposure can either affect circadian rhythms as well as up-regulate the expression of signals belonging to the endocannabinoid system, in both cases leading to a remarkable increase of lipid accumulation. These results warrant further research and increase the interest toward the identification of new mechanisms for EDC metabolic alterations. The last part of this review article condenses recent evidences on the ability of potential EDCs to cause “transgenerational effects” by a single prenatal or early life exposure. On this regard, there is compelling evidence that epigenetic modifications link developmental environmental insults to adult disease susceptibility. This review will contribute to summarize the mechanisms underlying the insurgence of EDC-induced metabolic alterations as well as to build integrated strategies for their better management. In fact, despite the large number of results obtained so far, there is still a great demand for the development of frameworks that can integrate mechanistic and toxicological/epidemiological observations. This would increase legal and governmental institution awareness on this critical environmental issue responsible for negative consequences in both wild species and human health. Keywords: phthalates, zebrafish (Danio rerio), metabolic disorders, epigenetic, reproduction